Denali Therapeutics (DNLI) Capital Leases (2024 - 2026)
Denali Therapeutics (DNLI) posted quarterly Capital Leases of $5.5 million for Q1 2026, down 1.61% year-over-year from $5.6 million in Q1 2025, and little changed quarter-over-quarter from $5.5 million in Q4 2025.
Denali Therapeutics (DNLI) Capital Leases (2024 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has reported Capital Leases for 3 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Leases fell 1.61% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (down 1.61% YoY), while the FY2025 annual figure was $5.5 million, down 1.48% from the prior year.
- Capital Leases held at $5.5 million in Q1 2026 per DNLI's latest filing, from $5.5 million in the prior quarter.
- Across five years, Capital Leases topped out at $5.6 million in Q3 2024 and bottomed at $5.5 million in Q1 2026.
- Historically, Capital Leases has averaged $5.6 million across 3 years, with a median of $5.6 million in 2025.
- Annual changes were most pronounced in 2025 — Capital Leases declined 1.37% — and 2026, when it decreased 1.61%.
- Denali Therapeutics' Capital Leases stood at $5.6 million in 2024, then dropped by 1.48% to $5.5 million in 2025, then retreated by 0.43% to $5.5 million in 2026.
- Business Quant data shows DNLI's Capital Leases at $5.5 million in Q1 2026, $5.5 million in Q4 2025, and $5.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.48 Mn |
| Mar 31, 2026 | 5.51 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Sep 30, 2024 | 5.63 Mn |